JPH0560839B2 - - Google Patents

Info

Publication number
JPH0560839B2
JPH0560839B2 JP61104787A JP10478786A JPH0560839B2 JP H0560839 B2 JPH0560839 B2 JP H0560839B2 JP 61104787 A JP61104787 A JP 61104787A JP 10478786 A JP10478786 A JP 10478786A JP H0560839 B2 JPH0560839 B2 JP H0560839B2
Authority
JP
Japan
Prior art keywords
lecithin
hexane
egg yolk
layer
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61104787A
Other languages
Japanese (ja)
Other versions
JPS62263192A (en
Inventor
Muneo Sakai
Emi Tokunaga
Masaaki Morikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oillio Group Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Priority to JP10478786A priority Critical patent/JPS62263192A/en
Publication of JPS62263192A publication Critical patent/JPS62263192A/en
Publication of JPH0560839B2 publication Critical patent/JPH0560839B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

「産業上の利用分野」 本発明はレシチンを卵黄から抽出製造する方法
に関する。特に医薬品等に用いることのできる高
純度のレシチンを衛生的に高収率で得ることので
きる方法に関する。 レシチンはその界面活性性から食品分野、医薬
品分野に利用されており、卵黄レシチンは乳化持
性、安全性から人工血液、リポ乳剤、ビタミンE
など医薬品分野の利用・開発が行われている。よ
つて安価に安全性の高い卵黄レシチンの製造方法
を確立することはこれらの産業への寄与は大であ
る。 「従来の技術」 卵黄レシチンの製造方法はいくつか知られてお
り、特公昭56−47915、特公昭46−42186特公昭37
−6259などが挙げられる。特公昭56−47915はジ
メチルエーテルで生卵黄からレシチン、中性脂質
および一部の水を抽出分離し脱溶剤後抽出油分中
の水分含量と調整することによりレシチンと中性
脂質を分離する方法である。この方法ではレシチ
ンは水と一緒に回収するため、その後脱水、乾燥
をする必要があるが、レシチンの品質に影響を及
ぼすため品温を高くすることができず高コストで
ある凍結乾燥を強いられるなどの欠点を有する。 特公昭46−42186は卵黄に半量から倍量の1価
アルコールと少量の酸を加えてPH3〜6程度にし
攪拌したのち、卵黄の倍量から4倍量の水を加え
て遠心分離するとによつて上層からリン脂質を含
まないトリグリセリド・ステリンの層をリン脂質
の層とたん白の層に分けることを特徴とする。こ
れは酸やアルコールによつてたん白を変性させる
ことによつて脂質とたん白質とを分離させやすい
形とし、通常植物油の脱ガム(リン脂質分の除
去)で知られるようにリン脂質が、水の存在下で
トリグリセリドなどの中性脂質に溶解しないこと
を利用して、水を加えトリグリセリドとの分離
を、更には比重差からたん白との分離を行うもの
である。 特公昭37−6259は酸を添加した無水アルコール
類で水分含量を37〜29%に半乾燥調整した卵黄を
浸漬処理濾過したのち、油脂溶剤を使用して抽出
卵黄油を得る方法である。この方法は半乾燥など
前処理工程が必要であり、酸の除去、濾過などの
工程が複雑であると共に得られる卵黄油は本発明
者らが期待する高純度のレシチンと異なり中性脂
質を含むものである。 レシチンは通常アセトンに不溶であるが、中性
脂質はアセトンに可溶であるため、この特性を利
用してレシチンを精製する方法も知られている
が、これらの方法では脱アセトンが容易ではなく
特有の臭いを有するメシチルオキシドが残留する
などの欠点がある。 以上の如く、これまで知られている方法は高コ
ストであつたり、工程が複雑であつたり、特有の
有臭の成分の含むなど、まだ改善される余地があ
る。 「発明が解決しようとする問題点」 本発明の目的は卵黄からレシチンを含む脂質を
抽出して該脂質からレシチンを製造するにあた
り、食品製造に一般的に用いられる安全な溶剤を
使用することができ、衛生的に安全で高純度のレ
シチンを高収率で得ることのできる方法を提供す
ることにある。 卵黄は水分約50%、たん白質約15%、脂質約35
%からなり、中性脂質がレシチン、コレステロー
ル、たん白によつて乳化された系となっている。
この乳化は非常に安定であるために単純にヘキサ
ン等の非極性溶剤によつて抽出操作を行なつても
非常に抽出率が低く、特に極性脂質であるリン脂
質は抽出されにくい。 本発明者らは乳化がレシチン、コレステロー
ル、たん白による作用であることに注目し、好ま
しくは凍結等によりたん白を変性させ、次いでア
ルコール類と非極性溶剤の混合溶剤を用いること
によつてこの乳化系を破壊し効率よく脂質を抽出
し、次いでこの抽出工程からレシチンと中性油を
簡便に分別して、レシチンを高収率で製造できる
方法を見い出し、本発明を完成するに至つた。 「問題点を解決するための手段」 すなわち、凍結卵黄中の脂質をエタノール/n
−ヘキサン=25/75〜15/85からなる混合溶剤で
抽出し、固液分離して得られる該混合溶剤層に1
価の金属塩を含有し、かつ該n−ヘキサンに対し
て0.01〜0.5倍容量の水を添加し、水−エタノー
ル層を分別し、得られたn−ヘキサン層を限外濾
過膜で処理するにあたり、該n−ヘキサン層に対
して約2倍容量のn−ヘキサンを用いて定容濾過
して高純度レシチンを高収率で得ることを特徴と
する卵黄レシチンの製造方法である。 以下、本発明を詳細に説明する。 本発明においては、卵黄からレシチンを抽出製
造するにあたり、まずアルコール類、非極性溶剤
から成る混合溶剤を卵黄に加えて攪拌後、固液分
離することによつてレシチンを含む脂質を抽出し
た溶剤を回収する。 この場合、好ましくは卵黄を凍結することによ
つて予め卵黄たん白質を変性させておくことによ
り抽出を効率的に行うことができる。 卵黄は産業上利用される場合、衛生上、保管上
凍結して利用されることが多いが、この際は食塩
など塩類や砂糖など糖類を添加することによつて
たん白質の変性を少なくして供給使用される。 本発明では卵黄をそのまま凍結することによつ
て積極的にたん白質を変性させその後の抽出率が
上がることを見い出した。凍結は衛生的であれば
瞬間凍結をする必要がなく通常冷凍配送される温
度に保管されれば良い。 本発明に用いられるアルコール類としては、メ
タノール、エタノール、プロパノール等を用いる
ことができるが、食品衛生上の観点からエタノー
ルを用いることが好ましい。非極性溶剤としては
ベンゼン、ヘキサン等が使用できるが、現在も食
品油抽出などに利用されているn−ヘキサンを用
いることが望ましい。混合溶剤の使用量は、抽出
効率の点から好ましくは凍結卵黄重量の1〜5倍
の容量である。 本発明に用いられる混合溶剤中のアルコール類
と非極性溶剤の混合比率はエタノール/n−ヘキ
サン=50/50〜10/90が好ましく更に好ましくは
25/75〜15/85である。第1表に示すようにアル
コール類の比率が多くなると抽出脂質中のリン脂
質含量は高くなるが、総脂質抽出率が低くなり、
好ましくない。またアルコール類の比率が低いと
総脂質抽出率も低いと同時にリン脂質含量も低く
なり好ましくない。これらの結果から上記の混合
比率が好ましい。
"Industrial Application Field" The present invention relates to a method for extracting and producing lecithin from egg yolk. In particular, the present invention relates to a method for hygienically obtaining high-yield lecithin of high purity that can be used in pharmaceuticals and the like. Lecithin is used in the food and pharmaceutical fields due to its surfactant properties, and egg yolk lecithin is used in artificial blood, lipoemulsions, and vitamin E due to its emulsification retention and safety.
It is being used and developed in the pharmaceutical field. Therefore, establishing a method for producing egg yolk lecithin that is inexpensive and highly safe will greatly contribute to these industries. ``Prior art'' There are several known methods for producing egg yolk lecithin.
-6259 etc. Japanese Patent Publication No. 56-47915 is a method for separating lecithin and neutral lipids by extracting and separating lecithin, neutral lipids, and some water from raw egg yolk with dimethyl ether, removing the solvent, and adjusting the water content in the extracted oil. . In this method, lecithin is recovered together with water, so it must be dehydrated and dried afterwards, but it is not possible to raise the temperature of the product because it affects the quality of the lecithin, forcing expensive freeze-drying. It has drawbacks such as: Japanese Patent Publication No. 46-42186 states that after adding half to twice the amount of monohydric alcohol and a small amount of acid to egg yolk and stirring to bring the pH to about 3 to 6, add water that is twice to four times the amount of egg yolk and centrifuge it. It is characterized by dividing the triglyceride/sterin layer, which does not contain phospholipids, into a phospholipid layer and a protein layer from the top layer. This is done by denaturing protein with acid or alcohol to make it easier to separate lipids and proteins, and as is known from the degumming (removal of phospholipid content) of vegetable oils, phospholipids are Taking advantage of the fact that neutral lipids such as triglycerides do not dissolve in the presence of water, water is added to separate them from triglycerides, and further from proteins based on the difference in specific gravity. Japanese Patent Publication No. 37-6259 discloses a method for obtaining extracted egg yolk oil by soaking and filtering egg yolks that have been semi-dried to a moisture content of 37 to 29% with acid-added absolute alcohol, and then using an oil-fat solvent. This method requires pretreatment steps such as semi-drying, and the steps such as acid removal and filtration are complicated, and the resulting egg yolk oil contains neutral lipids, unlike the high-purity lecithin expected by the present inventors. It is something that Lecithin is usually insoluble in acetone, but neutral lipids are soluble in acetone, so there are methods to purify lecithin that take advantage of this property, but these methods do not easily remove acetone. There are disadvantages such as residual mesityl oxide with a characteristic odor. As described above, the methods known so far are high in cost, have complicated steps, and contain components with specific odor, so there is still room for improvement. "Problems to be Solved by the Invention" The purpose of the present invention is to extract lipids containing lecithin from egg yolks and to produce lecithin from the lipids using safe solvents commonly used in food production. The object of the present invention is to provide a method capable of obtaining hygienically safe and highly purified lecithin at a high yield. Egg yolk is about 50% water, about 15% protein, and about 35% fat.
%, and is a system in which neutral lipids are emulsified with lecithin, cholesterol, and protein.
Since this emulsion is very stable, even if an extraction operation is performed simply with a non-polar solvent such as hexane, the extraction rate is very low, and in particular, phospholipids, which are polar lipids, are difficult to extract. The present inventors focused on the fact that emulsification is an effect of lecithin, cholesterol, and protein, and achieved this by preferably denaturing the protein by freezing, etc., and then using a mixed solvent of alcohols and non-polar solvents. The present invention was completed by discovering a method for producing lecithin in high yield by destroying the emulsification system and efficiently extracting lipids, and then easily separating lecithin and neutral oil from this extraction process. ``Means for solving the problem'' In other words, the lipids in frozen egg yolks were mixed with ethanol/n
-Extraction with a mixed solvent consisting of hexane = 25/75 to 15/85, followed by solid-liquid separation.
0.01 to 0.5 times the volume of water to the n-hexane is added, the water-ethanol layer is separated, and the resulting n-hexane layer is treated with an ultrafiltration membrane. This is a method for producing egg yolk lecithin, which is characterized in that high-purity lecithin is obtained at a high yield by volumetric filtration using n-hexane in an amount approximately twice the volume of the n-hexane layer. The present invention will be explained in detail below. In the present invention, when extracting and manufacturing lecithin from egg yolk, first, a mixed solvent consisting of alcohols and a non-polar solvent is added to the egg yolk, and after stirring, solid-liquid separation is performed to extract the lipids containing lecithin. to recover. In this case, the extraction can be carried out efficiently by denaturing the egg yolk protein in advance, preferably by freezing the egg yolk. When egg yolks are used industrially, they are often frozen for hygiene and storage reasons, but in this case, salts such as table salt and sugars such as sugar are added to reduce the denaturation of proteins. Supply used. In the present invention, we have discovered that by freezing the egg yolk as it is, the protein is actively denatured and the subsequent extraction rate is increased. If freezing is hygienic, there is no need to flash freeze the food, and it is sufficient to store it at the temperature at which it is normally shipped frozen. As the alcohol used in the present invention, methanol, ethanol, propanol, etc. can be used, but from the viewpoint of food hygiene, it is preferable to use ethanol. Benzene, hexane, etc. can be used as the non-polar solvent, but it is preferable to use n-hexane, which is currently used for food oil extraction. The amount of mixed solvent used is preferably 1 to 5 times the weight of the frozen egg yolk in terms of extraction efficiency. The mixing ratio of alcohol and non-polar solvent in the mixed solvent used in the present invention is preferably ethanol/n-hexane = 50/50 to 10/90, and more preferably
25/75 to 15/85. As shown in Table 1, when the ratio of alcohol increases, the phospholipid content in the extracted lipids increases, but the total lipid extraction rate decreases.
Undesirable. Moreover, if the ratio of alcohols is low, the total lipid extraction rate will be low, and at the same time, the phospholipid content will also be low, which is not preferable. From these results, the above mixing ratio is preferable.

【表】 固液分離した溶剤相にはレシチン、中性脂質な
どが抽出されるが、次工程で限外濾過処理するに
あたつて、アルーコル類の除去を行なわねばなら
ない。このため分離された溶剤相中の非極性溶剤
に対して0.01〜0.5部の水、好ましくは0.05〜0.3
部の水を加えることによつてアルコール類は水と
共に非極性溶媒から分離除去される。 こうして分離したアルコール類水層と非極性溶
媒層はデカンテーシヨンなどにより簡単に分離す
ることができる。 この過程でエタノールおよび水からなる極性溶
剤中にレシチンが若干溶解するが、上記範囲内の
水添加量であればその量は無視できる程度で工業
生産上無視できる程度であつた。 上記水に塩類を加えて検討した結果、1価の金
属塩例えば塩化ナトリウム、塩化カリウムを用い
ることによつて更に水層へのレシチンの分配は低
くなり歩留りも向上することが解かつた。但しカ
ルシウムやマグネシウムなど2価の金属塩を用い
るとレシチンと反応して不溶物を形成し歩留りが
低かつた。 その後得られるn−ヘキサン層を耐溶剤性のあ
る限外濾過膜を通すことによつてレシチン分と中
性脂質分に分画し、高純度のレシチンを得る。限
外濾過膜はレシチンの会合物と中性脂質が分画で
きる分画分子量5000以上であれば良く、純度を高
めるために同じ非極性溶剤を用いて定容濾過回分
濾過を繰り返えすこともできる。 このような限外濾過膜としては、ダイセル化学
工業(株)製のDUS−40(円管型モジユール、膜素
材:ポリエーテルサルホン、分画分子量:
40000)、ロミコン社製PM−10,30,50および
100中空糸モジユール、膜素材:ポリスルホン、
分画分子量は、それぞれ、5000,10000,30000,
50000および100000)、三井石油化学工業(株)製
IRIS−3038(平板型モジユール、膜素材:ポリア
クリロニトリル共重合体、分画分子量:15000〜
20000およびMPS−3400(平板型モジユール、膜
素材:ポリスルホン、分画分子量:30000〜
40000)などがある。 「実施例」 比較例 1 凍結卵黄1000gにヘキサン1000ml、エタノール
1000mlの混合溶剤を加え、ホモミキサーで5分間
攪拌したのち、3000rpm5分間遠心分離して溶剤
量1820mlを得た。この溶剤層に水300mlを加えて
混合静置したのち、デカンテーシヨンを行つてヘ
キサン層980mlを得た。ヘキサン層中の脂質含量
は25.8%であつた。これをダイセル化学工業(株)社
製限外濾過膜DUS−40(分画分子量40000)でヘ
キサン3000mlを用いて定容濾過を行い、90%純度
の卵黄レシチン82gを得た。 実施例 1 凍結卵黄1000gにヘキサン1600ml、エタノール
400mlの混合溶剤を加えホモミキサーで5分間攪
拌したのち、3000rpm5分間遠心分離して溶剤量
1960mlの溶剤層を得た。こお溶剤層に3%食塩水
200mlを加えて混合静置したのち、デカンテーシ
ヨンを行なつてヘキサン層1620mlを得た。ヘキサ
ン中の脂質含量は20.8%であつた。これを三井石
油化学工業(株)製限外濾過膜、MPS−3400(分画分
子量30000〜40000)で3000mlを用いて定容濾過を
行ない95%純度卵黄レシチン108gを得た。 「発明の効果」 以上から明らかな如く、本発明によれば医薬品
に用いることのできる高純度の卵黄レシチンを簡
便、高収率且つ衛生的に安全に製造することがで
きる。本発明によつて得られるレシチンはアセト
ン分別などによつて得られるものとは異なり非常
に風味の良いものであり、香粧品、食品等に乳化
剤、界面活性剤として利用価値が高いものであ
る。
[Table] Lecithin, neutral lipids, etc. are extracted from the solid-liquid separated solvent phase, but alcohols must be removed during ultrafiltration in the next step. For this purpose, 0.01 to 0.5 parts of water, preferably 0.05 to 0.3 parts, based on the non-polar solvent in the separated solvent phase.
By adding 50% of water, the alcohol is separated and removed from the nonpolar solvent together with water. The alcohol aqueous layer and the nonpolar solvent layer thus separated can be easily separated by decantation or the like. During this process, lecithin was slightly dissolved in the polar solvent consisting of ethanol and water, but if the amount of water added was within the above range, the amount was negligible and could be ignored in industrial production. As a result of studies on adding salts to the water, it was found that by using monovalent metal salts such as sodium chloride and potassium chloride, the distribution of lecithin to the aqueous layer was further reduced and the yield was improved. However, when divalent metal salts such as calcium and magnesium are used, they react with lecithin to form insoluble matter, resulting in a low yield. The resulting n-hexane layer is then passed through a solvent-resistant ultrafiltration membrane to be fractionated into a lecithin component and a neutral lipid component to obtain highly pure lecithin. The ultrafiltration membrane should have a molecular weight cutoff of 5000 or more that can separate lecithin aggregates and neutral lipids, and constant volume filtration and batch filtration may be repeated using the same nonpolar solvent to increase purity. can. As such an ultrafiltration membrane, DUS-40 (cylindrical module, membrane material: polyether sulfone, molecular weight cut off:
40000), Romicon PM-10, 30, 50 and
100 hollow fiber module, membrane material: polysulfone,
The molecular weight cutoff is 5000, 10000, 30000, respectively.
50000 and 100000), manufactured by Mitsui Petrochemical Industries, Ltd.
IRIS-3038 (flat plate module, membrane material: polyacrylonitrile copolymer, molecular weight cutoff: 15,000~
20000 and MPS-3400 (flat plate module, membrane material: polysulfone, molecular weight cutoff: 30000~
40000) etc. "Example" Comparative example 1 1000g of frozen egg yolk, 1000ml of hexane, ethanol
1000 ml of mixed solvent was added, stirred for 5 minutes using a homomixer, and then centrifuged at 3000 rpm for 5 minutes to obtain 1820 ml of solvent. After adding 300 ml of water to this solvent layer and allowing the mixture to stand, decantation was performed to obtain 980 ml of hexane layer. The lipid content in the hexane layer was 25.8%. This was subjected to constant volume filtration using an ultrafiltration membrane DUS-40 (molecular weight cut off: 40,000) manufactured by Daicel Chemical Industries, Ltd. using 3,000 ml of hexane to obtain 82 g of egg yolk lecithin with a purity of 90%. Example 1 1000g frozen egg yolk, 1600ml hexane, ethanol
Add 400ml of mixed solvent, stir for 5 minutes using a homomixer, and then centrifuge at 3000 rpm for 5 minutes to determine the amount of solvent.
A 1960ml solvent layer was obtained. 3% salt solution in the solvent layer
After adding 200 ml of the mixture and allowing it to stand, decantation was performed to obtain a hexane layer of 1,620 ml. The lipid content in hexane was 20.8%. This was subjected to constant volume filtration using 3,000 ml of an ultrafiltration membrane manufactured by Mitsui Petrochemical Industries, Ltd., MPS-3400 (molecular weight cut off: 30,000 to 40,000) to obtain 108 g of 95% pure egg yolk lecithin. "Effects of the Invention" As is clear from the above, according to the present invention, highly purified egg yolk lecithin that can be used in pharmaceuticals can be produced easily, in high yield, and hygienically and safely. The lecithin obtained by the present invention has a very good flavor, unlike that obtained by fractionating acetone, and has high utility value as an emulsifier or surfactant in cosmetics, foods, etc.

Claims (1)

【特許請求の範囲】 1 凍結卵黄中の脂質をエタノール/n−ヘキサ
ン=25/75〜15/85からなる混合溶剤で抽出し、
固液分離して得られる該混合溶剤層に1価の金属
塩を含有し、かつ該n−ヘキサンに対して0.01〜
0.5倍容量の水を添加し、水−エタノール層を分
別し、得られたn−ヘキサン層を限外濾過膜で処
理するにあたり、該n−ヘキサン層に対して約2
倍容量のn−ヘキサンを用いて定容濾過して高純
度レシチンを高収率で得ることを特徴とする卵黄
レシチンの製造方法。 2 凍結卵黄の1〜5倍容量の混合溶剤で抽出す
る特許請求の範囲第1項記載の製造方法。 3 1価の金属塩が塩化ナトリウムである特許請
求の範囲第1項記載の製造方法。 4 耐溶剤性の限外濾過膜の分画分子量が5000以
上である特許請求の範囲第1項記載の製造方法。
[Claims] 1. Extracting lipids in frozen egg yolk with a mixed solvent consisting of ethanol/n-hexane = 25/75 to 15/85,
The mixed solvent layer obtained by solid-liquid separation contains a monovalent metal salt, and the amount of the n-hexane is 0.01 to
0.5 times the volume of water is added, the water-ethanol layer is separated, and the resulting n-hexane layer is treated with an ultrafiltration membrane.
A method for producing egg yolk lecithin, which comprises obtaining high-purity lecithin at a high yield by volumetric filtration using twice the volume of n-hexane. 2. The manufacturing method according to claim 1, wherein extraction is performed with a mixed solvent of 1 to 5 times the volume of frozen egg yolk. 3. The manufacturing method according to claim 1, wherein the monovalent metal salt is sodium chloride. 4. The manufacturing method according to claim 1, wherein the solvent-resistant ultrafiltration membrane has a molecular weight cut off of 5,000 or more.
JP10478786A 1986-05-09 1986-05-09 Production of egg yolk lecithin Granted JPS62263192A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10478786A JPS62263192A (en) 1986-05-09 1986-05-09 Production of egg yolk lecithin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10478786A JPS62263192A (en) 1986-05-09 1986-05-09 Production of egg yolk lecithin

Publications (2)

Publication Number Publication Date
JPS62263192A JPS62263192A (en) 1987-11-16
JPH0560839B2 true JPH0560839B2 (en) 1993-09-03

Family

ID=14390177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10478786A Granted JPS62263192A (en) 1986-05-09 1986-05-09 Production of egg yolk lecithin

Country Status (1)

Country Link
JP (1) JPS62263192A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1335054C (en) * 1989-09-21 1995-04-04 Jeong S. Sim Extraction of fresh liquid egg yolk
IL147529A0 (en) * 2002-01-09 2002-08-14 Oladur Ltd A method for the production of soybean sugars and the product produced thereof
KR100446833B1 (en) * 2002-02-05 2004-09-04 강성식 Method of Producing Egg Yolk Lecithin
US10328105B2 (en) 2015-05-27 2019-06-25 Rimfrost Technologies As Flowable concentrated phospholipid krill oil composition
CN107459547B (en) * 2017-07-13 2022-08-26 浙江省农业科学院 Method for coproducing and separating various bioactive substances in egg yolk

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5647915A (en) * 1979-09-27 1981-04-30 Hitachi Metals Ltd Manufacture of magnetic head
JPS5763398A (en) * 1980-10-03 1982-04-16 Nisshin Oil Mills Ltd Treatment of oil and fat
JPS5829712A (en) * 1981-08-13 1983-02-22 Takeo Haneda Extraction and separation of lipid of sea snake
JPS60163888A (en) * 1984-02-03 1985-08-26 Pola Chem Ind Inc Production of lipid component

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5647915A (en) * 1979-09-27 1981-04-30 Hitachi Metals Ltd Manufacture of magnetic head
JPS5763398A (en) * 1980-10-03 1982-04-16 Nisshin Oil Mills Ltd Treatment of oil and fat
JPS5829712A (en) * 1981-08-13 1983-02-22 Takeo Haneda Extraction and separation of lipid of sea snake
JPS60163888A (en) * 1984-02-03 1985-08-26 Pola Chem Ind Inc Production of lipid component

Also Published As

Publication number Publication date
JPS62263192A (en) 1987-11-16

Similar Documents

Publication Publication Date Title
JP5461750B2 (en) Method for fractionating natural substances containing oil and polar lipids
JP2977286B2 (en) Oilseed protein extraction method
AU2012242355B2 (en) A process for the isolation of a phospholipid
JPS6133544B2 (en)
JPH11512477A (en) Fractionated vegetable oil
US7550616B2 (en) Method for the fractionation of oil and polar lipid-containing native raw materials
JPH0560839B2 (en)
JPH0320397A (en) Highly fresh fish oil containing fish phospholipid and its preparation
KR100446833B1 (en) Method of Producing Egg Yolk Lecithin
JP3655435B2 (en) Method for producing egg yolk lecithin
WO2006036732A2 (en) Process for releasing and extracting phosphatides from a phosphatide-containing matrix
JPH0726287A (en) Production of yolk lipid
EP3860353A1 (en) Method for producing a phospholipid concentrate from a dairy composition
JP3807688B2 (en) Method for producing dried lecithin
EP2168438A1 (en) Composition richly containing polar lipid and method of manufacturing the same
US11623905B2 (en) Isolation and crystallization of cannabinoids without distillation or evaporation of solvents
JP6749955B2 (en) Method for producing emulsified composition
SU1463743A1 (en) Method of recovering fat from waste of mayonnaise production
KR20000020072A (en) Method for separating yolk oil and sialyl oligosaccharine from egg yolk
JP2515839B2 (en) Phospholipid purification method
JP3616700B2 (en) Egg yolk phospholipid composition
TW202102126A (en) Method for producing phospholipid concentrate standing a mixed solution of a bird breast meat ethanol extracting solution concentrate and 40% to 60% by mass of ethanol aqueous solution
JPH0698721A (en) Production of yolk oil
EP2163160A1 (en) Composition richly containing polar lipid and method of manufacturing the same
JPH11332518A (en) Production of low cholesterol yolk